tiprankstipranks
Trending News
More News >
Apimeds Pharmaceuticals US, Inc. (APUS)
:APUS
US Market
Advertisement

Apimeds Pharmaceuticals US, Inc. (APUS) Technical Analysis

Compare
12 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
2Neutral
5Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
0Bearish
Apimeds Pharmaceuticals US, Inc.’s (APUS) Moving Averages Convergence Divergence (MACD) indicator is 0.03, suggesting Apimeds Pharmaceuticals US, Inc. is a Sell.
Apimeds Pharmaceuticals US, Inc.’s (APUS) 20-Day exponential moving average is 1.89, while Apimeds Pharmaceuticals US, Inc.’s (APUS) share price is $2.03, making it a Buy.
Apimeds Pharmaceuticals US, Inc.’s (APUS) 50-Day exponential moving average is 1.87, while Apimeds Pharmaceuticals US, Inc.’s (APUS) share price is $2.03, making it a Buy.

Apimeds Pharmaceuticals US, Inc. (APUS) Pivot Points

Oct 30, 2025, 08:29 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.73
1.79
1.91
1.98
2.10
2.16
2.29
Fibonacci
1.79
1.86
1.90
1.98
2.05
2.09
2.16
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Apimeds Pharmaceuticals US, Inc. (APUS) Moving Averages

Oct 30, 2025, 08:29 PM
Period
Simple
Exponential
MA5
1.94Buy
1.97Buy
MA10
1.89Buy
1.92Buy
MA20
1.85Buy
1.89Buy
MA50
1.89Buy
1.87Buy
MA100
1.84Buy
1.84Buy
MA200
Apimeds Pharmaceuticals US, Inc.’s (APUS) 10-Day exponential moving average is 1.92, while Apimeds Pharmaceuticals US, Inc.’s (APUS) share price is $2.03, making it a Buy.
Apimeds Pharmaceuticals US, Inc.’s (APUS) 100-Day exponential moving average is 1.84, while Apimeds Pharmaceuticals US, Inc.’s (APUS) share price is $2.03, making it a Buy.
Apimeds Pharmaceuticals US, Inc.’s (APUS) stock price is $2.03 and Apimeds Pharmaceuticals US, Inc.’s (APUS) 50-day simple moving average is 1.89, creating a Buy signal.
Apimeds Pharmaceuticals US, Inc.’s (APUS) stock price is $2.03 and Apimeds Pharmaceuticals US, Inc.’s (APUS) 100-day simple moving average is 1.84, creating a Buy signal.

Apimeds Pharmaceuticals US, Inc. (APUS) Technical Indicators

Oct 30, 2025, 08:29 PM
Name
Value
Implied Action
RSI (14)
57.34
Neutral
STOCH (9,6)
85.87
Sell
STOCHRSI (14)
85.87
Sell
MACD (12,26)
0.03
Sell
ADX (14)
12.30
Buy
Williams %R
-13.65
Sell
CCI (14)
226.45
Sell
ATR (14)
0.15
-
Ultimate Oscillator
59.59
Neutral
ROC
9.14
Buy
Apimeds Pharmaceuticals US, Inc.’s (APUS) Relative Strength Index (RSI) is 57.34, creating a Neutral signal.
Apimeds Pharmaceuticals US, Inc.’s (APUS) Trend Strength Indicator (ADX) is 12.30, creating a Buy signal.
Apimeds Pharmaceuticals US, Inc.’s (APUS) Commodity Channel Index (CCI) is 226.45, creating a Sell signal.
Apimeds Pharmaceuticals US, Inc.’s (APUS) Price Rate of Change (ROC) is 9.14, creating a Buy signal.

FAQ

Is APUS a Buy, Hold, or Sell?
Based on APUS’s technical indicators, APUS is a Buy.
    What is APUS’s RSI (14)?
    APUS’s RSI (14) is 57.34, which suggests APUS is a Neutral.
      What is APUS’s MACD?
      APUS’s MACD is 0.03, which suggests APUS is a Sell.
        What is APUS’s 5-day moving average?
        APUS’s 5-day moving average is 1.94, which suggests APUS is a Buy.
          What is APUS’s 20-day moving average?
          APUS 20-day moving average is 1.85, which suggests APUS is a Buy.
            What is APUS’s 50-day moving average?
            APUS’s 50-day moving average is 1.89, which suggests APUS is a Buy.
              What is APUS’s 200-day moving average?
              Currently, no data Available
              What is APUS’s Williams % R (14)?
              APUS’s Williams % R (14) is -13.65, which suggests APUS is a Sell.
                What is APUS’s CCI (14)?
                APUS’s CCI (14) is 226.45, which suggests APUS is a Sell.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis